Genvor to Present at Centri Capital Conference

Biotech company to showcase AI-generated peptides at investment event in New York City

Apr. 7, 2026 at 12:10pm

Got story updates? Submit your updates here. ›

A photorealistic studio still life featuring a collection of polished, geometric shapes and premium materials arranged elegantly on a clean, monochromatic background, symbolizing the abstract concepts of biotechnology, AI, and capital markets.A conceptual still life representing the innovative biotechnology and capital markets industries converging at the Centri Capital Conference.Woodland Today

Genvor, a biotechnology company using AI to develop novel peptides for agriculture and human health, will present at the upcoming Centri Capital Conference in New York City on April 14. CEO Chad Pawlak will discuss the company's recent performance and future growth plans at the event, which will gather investment bankers, private equity investors, and other capital markets participants.

Why it matters

The Centri Capital Conference is an important platform for emerging biotech companies like Genvor to showcase their innovations and connect with potential investors. Genvor's presentation will highlight its proprietary BioCypher platform, which uses AI to design peptides that can enhance crop performance and support human wellness, potentially drawing interest from the investment community.

The details

Genvor, which trades on the OTCQB exchange, will be one of several exciting and disruptive companies presenting at the Centri Capital Conference, which is being held at the Nasdaq in New York City. The event will feature company presentations, investor 1-on-1 meetings, and panel discussions with industry thought leaders.

  • The Centri Capital Conference will take place on Tuesday, April 14, 2026.
  • Genvor's presentation is scheduled for that day.

The players

Genvor

A biotechnology company that uses AI to generate novel peptides for agriculture and human health applications.

Chad Pawlak

The Chief Executive Officer of Genvor, who will be presenting the company's recent performance and future growth plans at the Centri Capital Conference.

Centri Business Consulting

The organizer of the Centri Capital Conference, which gathers investment bankers, private equity investors, and other capital markets participants.

Michael Aiello

The CEO and Managing Partner of Centri Business Consulting, who stated that the companies involved in the Centri Capital Conference embody the innovation and diversity shaping today's capital markets.

Got photos? Submit your photos here. ›

What they’re saying

“The companies involved with the Centri Capital Conference embody the innovation and diversity shaping today's capital markets. We are excited to welcome them to Nasdaq for investor 1:1 meetings and meaningful exchanges with leaders from across the industry.”

— Michael Aiello, CEO & Managing Partner, Centri Business Consulting

What’s next

Companies and investors interested in presenting, attending, or sponsoring the Centri Capital Conference can learn more at www.CentriConsulting.com/capital-conference.

The takeaway

Genvor's presentation at the Centri Capital Conference represents an important opportunity for the biotech company to showcase its AI-powered peptide technology to potential investors in the capital markets. The event's focus on innovation and diversity aligns with Genvor's mission to develop high-performance solutions for agriculture and human health.